Infection Control & Hospital Epidemiology
5. Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B. Estimating the cost of health care-associated infections: mind your p’s and q’s. Clin Infect Dis 2010;50:1017–1021.
6. De Angelis G, Murthy A, Beyersmann J, Harbarth S. Estimating the impact of healthcare-associated infections on length of stay and costs. Clin Microbiol Infect 2010;16:1729–1735.
7. Smith R, Coast J. The Economic Burden of Antimicrobial Resistance: why it is More Serious than Current Studies Suggest. London: London School of Hygiene and Tropical Medicine; 2012.
8. Roberts RR, Hota B, Ahmad I, et al. Hospital and societal costs of antimi- crobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 2009;49:1175–1184.
9. Smith RD, Yago M, Millar M, Coast
J.Assessing themacroeconomic impact of a healthcare problem: the application of computable general equilibrium analysis to antimicrobial resistance. JHealthEcon 2005;24:1055–1075.
10. O’Neill J. Review on antimicrobial resistance: tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance website.
https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20- %20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth% 20of%20nations_1.pdf. Published 2014. Accessed January 9, 2019.
11. de Kraker ME, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med 2016;13: e1002184.
12. Gram Negative Sepsis Outcome Programme (GNSOP). 2015 antimicrobial susceptibility report. Australian Group on Antimicrobial Resistance (AGAR) website.
http://agargroup.org.au/wp-content/uploads/2017/08/July.2016.
AGAR-GNSOP-2015-Report-FINAL.pdf. Published 2016. Accessed January 9, 2019.
13. Stewardson AJ, Allignol A, Beyersmann J, et al. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study. Euro Surveill 2016;21(33):pii=30319. doi: 10.2807/
1560-7917.ES.2016.21.33. 30319.
14. Lambert ML, Suetens C, Savey A, et al. Clinical outcomes of health-care- associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011; 11:30–38.
15. Coombs GW, Pearson JC, Le T, et al. Australian Enterococcal Sepsis Outcome Progamme, 2015. Commun Dis Intell Qtrly Rept 2015;38: E247–E252.
16. Cheah AL, Spelman T, Liew D, et al. Enterococcal bacteremia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect 2013;19:E181–E189.
17. Salgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 2003;24: 690–698.
327
18. Australian Staphylococcal Sepsis Outcome Program (ASSOP) 2015: final report. Australian Group on Antimicrobial Resistance (AGAR) website.
http://agargroup.org.au/wp-content/uploads/2017/08/July.2016.ASSOP- 2015-Final-Report-2016-1.pdf. Published 2016. Accessed January 9, 2019.
19. Bowman KO, Shenton LR. Methods of Moments. Encyclopedia of Statistical Sciences, 2nd ed. John Wiley & Sons; 1985: 467–473.
20. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–332.
21. Australian Institute of Health and Welfare. Hospital Resources 2013–14: Australian Hospital Statistics. Health Services Series no. 63. Cat. no. HSE 160. Canberra: Australian Institute of Health and Welfare; 2015.
22. Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 2011;14:381–386.
23. Wozniak TM. Clinical management of drug-resistant bacteria in Australian hospitals: an online survey of doctors’ opinions. Infect Dis Health 2018;23:41–48.
24. Antibiotic Expert GroupseTGcomplete. Therapeutic Guidelines: antibiotic, version 15. Therapeutic Guidelines Limited website.
https://tgldcdp.tg.org. au/etgcomplete. Published 2016. Accessed January 9, 2019.
25. Independent Hospital Pricing Authority Annual Report 2014–15. Independent Hospital Pricing Authority (IHPA) website. https://www.
ihpa.gov.au/publications/annual-report-2014-15. Published 2015. Accessed January 9, 2019.
26. A comprehensive integrated surveillance program to improve Australia’s response to antimicrobial resistance. Expert Advisory Group on Anti- microbial Resistance website.
http://agargroup.org.au/wp-content/uploads/ 2017/08/EAGAR-Report-2006.pdf. Published 2006. Accessed January 9, 2019.
27. Mitchell BG, Ferguson JK, AndersonM, Sear J, Barnett A. Length of stay and mortality associated with healthcare-associated urinary tract infections: a multi-state model. J Hosp Infect 2016;93:92–99.
28. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994;3:95–104.
29. Staphylococcus aureus bacteraemia in Australian public hospitals 2014–15. Australian Institute of Health and Welfare (AIHW) website. https://
www.aihw.gov.au/reports/hospitals/staphylococcus-aureus-bacteraemia- in-australian-pu-1/contents/table–of-contents. Published 2015. Accessed January 9, 2019.
30. de Kraker ME, Jarlier V,MonenJC, Heuer OE, van de Sande N, Grundmann H. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect 2013;19:860–868.
31. Wozniak TM, Graves N, Barnett AG. How much do superbugs cost Australian hospitals? an evidence-based open-access tool. Infect Dis Health 2018;23:2.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132
